Page 72 - GPD-2-3
P. 72
Gene & Protein in Disease Testosterone as a biomarker of colorectal cancer
21. Orsted DD, Nordestgaard BG, Bojesen SE, 2014, Plasma Cancer Epidemiol Biomarkers Prev, 9(5): 517–521.
testosterone in the general population, cancer prognosis and 32. Hundt S, Haug U, Brenner H, 2007, Blood markers for early
cancer risk: A prospective cohort study. Ann Oncol, 25(3): detection of colorectal cancer: A systematic review. Cancer
712–718.
Epidemiol Biomarkers Prev, 16(10): 1935–1953.
https://doi.org/10.1093/annonc/mdt590
https://doi.org/10.1158/1055-9965.EPI-06-0994
22. Krasanakis T, Nikolouzakis TK, Sgantzos M, et al., 2019, 33. Locker GY, Hamilton S, Harris J, et al., 2006, ASCO 2006
Role of anabolic agents in colorectal carcinogenesis: Myths update of recommendations for the use of tumor markers in
and realities (Review). Oncol Rep, 42(6): 2228–2244.
gastrointestinal cancer. J Clin Oncol, 24(33): 5313–5327.
https://doi.org/10.3892/or.2019.7351
https://doi.org/10.1200/JCO.2006.08.2644
23. Ben-Batalla I, Vargas-Delgado ME, Von Amsberg G, 34. Hyde Z, Flicker L, McCaul KA, et al., 2012, Associations
et al., 2020, Influence of androgens on immunity to self and between testosterone levels and incident prostate, lung,
foreign: Effects on immunity and cancer. Front Immunol, and colorectal cancer. A population-based study. Cancer
11: 1184.
Epidemiol Biomarkers Prev, 21(8): 1319–1329.
https://doi.org/10.3389/fimmu.2020.01184
https://doi.org/10.1158/1055-9965.EPI-12-0129
24. Yang W, Giovannucci EL, Hankinson SE, et al., 2020,
Endogenous sex hormones and colorectal cancer survival 35. Chakraborty S, Pramanik J, Mahata B, 2021, Revisiting
among men and women. Int J Cancer, 147(4): 920–930. steroidogenesis and its role in immune regulation with the
advanced tools and technologies. Genes Immun, 22(3): 125–140.
https://doi.org/10.1002/ijc.32844
https://doi.org/10.1038/s41435-021-00139-3
25. Khaw KT, Dowsett M, Folkerd E, et al., 2007, Endogenous 36. Lee HK, Lee JK, Cho B, 2013, The role of androgen in
testosterone and mortality due to all causes, cardiovascular the adipose tissue of males. World J Mens Health, 31(2):
disease, and cancer in men: European prospective
investigation into cancer in Norfolk (EPIC-Norfolk) 136–140.
prospective population study. Circulation, 116: 2694–2701. https://doi.org/10.5534/wjmh.2013.31.2.136
https://doi.org/10.1161/circulationaha.107.719005 37. Chen E, Xu X, Liu T, 2018, Hereditary nonpolyposis
colorectal cancer and cancer syndromes: Recent basic and
26. Younis M, Arun M, Iqbal J, et al., 2018, Analysis of genetic clinical discoveries. J Oncol, 2018: 3979135.
alterations in colorectal cancer (CRC) patients in South
Indian population. Int J Hum Genet, 18(3): 210–218. https://doi.org/10.1155/2018/3979135
https://doi.org/10.31901/24566330.2018/18.3.705 38. Li H, Pham T, McWhinney BC, et al., 2016, Sex hormone
binding globulin modifies testosterone action and
27. Harman SM, Metter EJ, Tobin JD, et al., 2001, Longitudinal
effects of aging on serum total and free testosterone levels in metabolism in prostate cancer cells. Int J Endocrinol,
healthy men. Baltimore longitudinal study of aging. J Clin 2016: 6437585.
Endocrinol Metab, 86: 724–731. https://doi.org/10.1155/2016/6437585
https://doi.org/10.1210/jcem.86.2.7219 39. Roshni K, Younis M, Ilakkiyapavai D, et al., 2018, Anticancer
activity of biosynthesized silver nanoparticles using Murraya
28. Chen CC, Yang SH, Lin JK, et al., 2005, Is it reasonable to
add preoperative serum level of CEA and CA19-9 to staging koenigii leaf extract against HT-29 colon cancer cell line.
for colorectal cancer? J Surg Res, 124(2): 169–174. J Cancer Sci Ther, 10(4): 72–75.
https://doi.org/10.4172/1948-5956.1000521
https://doi.org/10.1016/j.jss.2004.08.013
40. Saddozai UA, Wang F, Akbar MU, et al., 2021, Identification of
29. Weissenberger C, Von Plehn G, Otto F, et al., 2005, clinical relevant molecular subtypes of pheochromocytoma.
Adjuvant radiochemotherapy of stage II and III rectal
adenocarcinoma: Role of CEA and CA 19-9. Anticancer Res, Front Endocrinol (Lausanne), 12: 605797.
25(3A): 1787–1793. https://doi.org/10.3389/fendo.2021.605797
30. Mohd Y, Balasubramanian B, Meyyazhagan A, et al., 2021, 41. Saddozai UA, Wang F, Cheng Y, et al., 2020, Gene expression
Extricating the association between the prognostic factors profile identifies distinct molecular subtypes and potential
of colorectal cancer. J Gastrointest Cancer, 52: 1022–1028. therapeutic genes in Merkel cell carcinoma. Transl Oncol,
13(11): 100816.
https://doi.org/10.1007/s12029-020-00535-4
https://doi.org/10.1016/j.tranon.2020.100816
31. Alberg AJ, Gordon GB, Hoffman SC, et al., 2000, Serum
dehydroepiandrosterone and dehydroepiandrosterone 42. Akbar MU, Badar M, Zaheer M, 2022, Programmable drug
sulfate and the subsequent risk of developing colon cancer. release from a dual-stimuli responsive magnetic metal-
Volume 2 Issue 3 (2023) 9 https://doi.org/10.36922/gpd.1082

